Chymotrypsin which is the endopeptidase extracted and separated from the fresh pancreas of bovine (or porcine).
View Details
Trypsin is a kind of serine proteolytic enzyme, with molecular weight of 23300 dalton, and is a single peptide chain composed of 223 amino acid residues.
View Details
Trypsin-Chymotrypsin is the co-crystal of Chymotrypsin and Trypsin so it has the properties of both.
View Details
Trypsin-Chymotrypsin is the co-crystal of Chymotrypsin and Trypsin so it has the properties of both.
View Details
Trypsin-Chymotrypsin is the co-crystal of Chymotrypsin and Trypsin so it has the properties of both.
View Details
Serrapeptase is a protein decomposition enzymes produced by bacteria serratia . Can decompose slow bradykinin, fibrin and fibrinogen.
View Details
About Us
Company establishment
Occupation of production workshop
Trypsin 10 tons/year
Chymotrypsin 10 tons/year
Pancreatic chymotrypsin 50 tons/year
Ribonuclease A 100kg/year
Beijing Geyuantianrun Bio-tech Co., Ltd., Ltd. is a national high-tech enterprise focusing on the international biopharmaceutical field, integrating R & D, production, sales and service, and a key foreign exchange income-generating enterprise of Beijing Municipal Commission of Commerce. The company's main products include trypsin, chymotrypsin, RNA-a enzyme and other functional biological enzymes and APIs. Geyuan Tianrun has always been adhering to the core concept of "quality is productivity", constantly innovating technology and products, and injecting new vitality into the high-quality development of world medicine with vigorous momentum.
View Details
To the beginning of the heart to the future to the quality of Bo development
Geyuan Tianrun always adheres to excellence, pursues excellent quality, makes full use of existing products and marketing advantages, integrates excellent technical strength, seizes the strategic opportunity of China's rapid economic development in the next ten years, and casts industry brands,
Quality Management
The company implements the advanced GMP (Good Manufacturing Practice for Drugs) management and detection system covering USP (United States Pharmacopoeia)/EP (European Pharmacopoeia)/CP (Chinese Pharmacopoeia)/BP (British Pharmacopoeia) standards. With its outstanding strength, the company has successfully passed the strict examination of FDA and DMF (Drug Master Document) registration, and has obtained USP certificate, ISO9001-2015 certificate and other certificates every year, highly recognized by many international authorities.
View Details
The company implements an advanced GMP (Good Manufacturing Practice) management and testing system that covers USP (United States Pharmacopeia) / EP (European Pharmacopoeia) / CP (Chinese Pharmacopoeia) / BP (British Pharmacopoeia) standards. With its outstanding capabilities, it has successfully passed the rigorous review by the US FDA and registered the DMF (Drug Master File). Each year, it obtains various certifications, including the USP certificate and ISO 9001 - 2015 certificate, receiving high recognition from multiple international authoritative organizations.
The multi-channel model realizes the transformation and industrialization of research and development achievements, providing customers with products and services with higher technological content.
The company strictly implements the operation of the quality system and ensures strict technical control over the execution of the quality system.
Honor
Industry Trends
12/19
In the first half of this year, against the backdrop of global economic stagnation, the market for pharmaceutical raw materials, which are essential for public health, has been relatively stable and less affected by fluctuations. Although the growth rate of the global pharmaceutical market has slowed down, it continues to progress steadily. According to data from the China Chamber of Commerce for Import and Export of Medicines and Health Products, in the first half of 2024, China's total import and export value of raw materials reached 26.52 billion USD, a year-on-year increase of 0.6%. Among them, the export value was 21.34 billion USD, a slight increase of 0.1% year-on-year; the import value was 5.18 billion USD, a year-on-year increase of 2.8%. With the expiration of patents, the generic drug market is ushering in new development opportunities, providing new market space for raw material pharmaceutical companies.
BGB Dynamics
01/07
Analysis of Global Pharmaceutical Product Market in 2020
According to the forecast of IMS, global pharmaceutical product trading volume in 2020 will reach 4.5 trillion unit doses, up 24% from 2015; the total spending is expected to exceed USD1.4 trillion, up 29%-32% from 2015.
Fine arts and wisdom, temper classic
Address：No. 3 Tianfu Road, Daxing Bio-medicine Industry Park, Beijing, China.
Telephone：010-60270888-821/820/811 010-60279131
Mailbox：sales@bjgytr.com gytr@bjgytr.com
Fax：010-60279131
Copyright©2024 Beijing Geyuan Tianrun Biotechnology Co., Ltd.
Power by :300.cn Beijing | SEO Tags | Privacy Agreement
